Zhang X - Search Results

1

PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy.

Xu Y, Gao Z, Hu R, Wang Y, Wang Y, Su Z, Zhang X, Yang J, Mei M, Ren Y, Li M, Zhou X. Xu Y, et al. Among authors: zhang x. J Immunother Cancer. 2021 Oct;9(10):e002699. doi: 10.1136/jitc-2021-002699. J Immunother Cancer. 2021. PMID: 34697216 Free PMC article.

2

PD-L2 based immune signature confers poor prognosis in HNSCC.

Qiao Y, Liu C, Zhang X, Zhou Q, Li Y, Xu Y, Gao Z, Xu Y, Kong L, Yang A, Mei M, Ren Y, Wang X, Zhou X. Qiao Y, et al. Among authors: zhang x. Oncoimmunology. 2021 Aug 4;10(1):1947569. doi: 10.1080/2162402X.2021.1947569. eCollection 2021. Oncoimmunology. 2021. PMID: 34377590 Free PMC article.

3

First-line treatment options for advanced non-small cell lung cancer patients with PD-L1 ≥ 50%: a systematic review and network meta-analysis.

He M, Zheng T, Zhang X, Peng Y, Jiang X, Huang Y, Tan B, Yang Z. He M, et al. Among authors: zhang x. Cancer Immunol Immunother. 2022 Jun;71(6):1345-1355. doi: 10.1007/s00262-021-03089-x. Epub 2021 Oct 16. Cancer Immunol Immunother. 2022. PMID: 34657171 Free PMC article.

4

HDAC6 inhibitor ACY-1215 enhances STAT1 acetylation to block PD-L1 for colorectal cancer immunotherapy.

Wen Y, Ye S, Li Z, Zhang X, Liu C, Wu Y, Zheng R, Xu C, Tian J, Shu L, Yan Q, Ai F, Ma J. Wen Y, et al. Among authors: zhang x. Cancer Immunol Immunother. 2024 Jan 17;73(1):7. doi: 10.1007/s00262-023-03624-y. Cancer Immunol Immunother. 2024. PMID: 38231305 Free PMC article.

5

Proinflammatory S100A8 Induces PD-L1 Expression in Macrophages, Mediating Tumor Immune Escape.

Li Z, Wang J, Zhang X, Liu P, Zhang X, Wang J, Zheng X, Wei L, Peng Q, Liu C, Yan Q, Shen S, Li X, Ma J. Li Z, et al. Among authors: zhang x. J Immunol. 2020 May 1;204(9):2589-2599. doi: 10.4049/jimmunol.1900753. Epub 2020 Mar 20. J Immunol. 2020. PMID: 32198140

6

Successful management of lung adenocarcinoma with ALK/EGFR co-alterations and PD-L1 over-expression by bevacizumab combined with chemotherapy.

He H, Yang W, Huang Y, Zhang X, Peng Y, Yang Z. He H, et al. Among authors: zhang x. Angiogenesis. 2022 Feb;25(1):5-8. doi: 10.1007/s10456-021-09811-8. Epub 2021 Aug 3. Angiogenesis. 2022. PMID: 34342748

7

Dioscin inhibiting EGFR-mediated Survivin expression promotes apoptosis in oral squamous cell carcinoma cells.

Li M, Zhao Q, Liao J, Wang X, Liu L, Zhang X, Liu L, Liu H, Zhang S. Li M, et al. Among authors: zhang s, zhang x. J Cancer. 2023 Jul 9;14(11):2027-2038. doi: 10.7150/jca.85011. eCollection 2023. J Cancer. 2023. PMID: 37497406 Free PMC article.

8

The transcription factor RUNX2 fuels YAP1 signaling and gastric cancer tumorigenesis.

Guo Z, Zhou K, Wang Q, Huang Y, Ji J, Peng Y, Zhang X, Zheng T, Zhang Z, Chong D, Yang Z. Guo Z, et al. Among authors: zhang z, zhang x. Cancer Sci. 2021 Sep;112(9):3533-3544. doi: 10.1111/cas.15045. Epub 2021 Jul 16. Cancer Sci. 2021. PMID: 34160112 Free PMC article.

9

N6-methyladenosine regulates ATM expression and downstream signaling.

Zhang X, Liu P, Zheng X, Wang J, Peng Q, Li Z, Wei L, Liu C, Wu Y, Wen Y, Yan Q, Ma J. Zhang X, et al. J Cancer. 2021 Oct 17;12(23):7041-7051. doi: 10.7150/jca.64061. eCollection 2021. J Cancer. 2021. PMID: 34729106 Free PMC article.

10

ADAR1 is a prognostic biomarker and is correlated with immune infiltration in lung adenocarcinoma.

Yang W, Chen K, Yu Q, Liao R, He H, Peng Y, Yang Z, Zhang X. Yang W, et al. Among authors: zhang x. Cancer Med. 2023 Jul;12(13):14820-14832. doi: 10.1002/cam4.6044. Epub 2023 May 10. Cancer Med. 2023. PMID: 37162299 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182,259 results

Search Page

Filters